August 9, 2021 07:03 AM EDT

Most Favored Nations rule for drug pricing: Gone, but not forgotten

Zachary Brennan

Senior Editor

The Centers for Medicare and Medicaid Services late Friday proposed to rescind another Trump-era drug pricing rule, this time for a rule that sought to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Most Favored Nations rule for drug pricing: Gone, but not forgotten

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer

AbbVie doubles down on siRNA with $335M upfront bet on ADARx

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

RFK Jr. defends HHS staff cuts, reorganization plans in House, Senate hearings

RFK Jr. says his opinions of vaccines are ‘irrelevant.’ Former FDA chief Califf disagrees

Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B

Most Fa­vored Na­tions rule for drug pric­ing: Gone, but not for­got­ten

Senior Editor

Sign up to read this article for free.

more like this

Celldex Therapeutics

Hampton, NJ, USA

Most Favored Nations rule for drug pricing: Gone, but not forgotten